


Foundayo® (orforglipron) is one of the first FDA approved small-molecule GLP-1 pills. Unlike other oral GLP-1s, you can take it any time of day, with or without food. If prescribed, it ships straight to your door.

Wegovy® (semaglutide) is the same clinically-studied GLP-1 you've heard about, now available as a once-daily pill. If you've been considering semaglutide, but wanted to skip the injection, an oral GLP-1 option may be a convenient alternative.











Medication pricing starts at $149/month for new members using cash pay. Price does not include the $125/month Shed Membership and provider fee, paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy.
Foundayo® (orforglipron) and Wegovy® (semaglutide) are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response.
A licensed provider will evaluate and prescribe medication when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider's discretion.
Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party dispensing pharmacy. Medications carry risks and side effects. Members should review the full Prescribing Information and discuss risks with their provider.
*In the ATTAIN-1 Phase 3 clinical trial, participants taking the highest dose of Foundayo® who completed 72 weeks of treatment in combination with diet and exercise lost an average of 12.4% of their body weight (27.3 pounds), compared to 0.9% with placebo, when combined with a reduced-calorie diet and increased physical activity. Source: Foundayo Prescribing Information. Lilly USA, LLC, 2026. *In clinical trials, adults using Wegovy® with diet and exercise achieved average weight loss of 14% over 68 weeks. Individual results may vary.
**Complimentary 1-on-1 coaching refers to 1 free virtual visit with a Shed Health Coach each month as well as free text-based coaching. Free text-based coaching may include automated responses generated by an AI assistant. All communication is monitored and reviewed by a licensed coach for accuracy, safety, and quality of support. AI does not replace professional medical or mental health advice.
Foundayo® is a registered trademark of Eli Lilly and Company. Wegovy® is a registered trademark of Novo Nordisk. Shed is not affiliated with or endorsed by Eli Lilly and Company or Novo Nordisk.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance